Atlas Trials

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT00079053 · COMPLETED

Trial details

NCT number
NCT00079053
Sponsor
NCIC Clinical Trials Group
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2004-03-02
Primary completion
2008-12-09
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.